3rd Quarter - Report

FEDERAL CITY STRATEGIES for DAVITA INC

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Healthcare reimbursement policy. H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015. Medicare payment for End Stage Renal Disease (ESRD). Education related to the issue that ESRD patients have access to Medicare Advantage plans.

LobbyistCovered position, as disclosed
SARAH HAMLETT —
MEGHAN JOHNSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1130 (114th)

Health Issues HCR

Healthcare reimbursement policy. H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015. Medicare payment for End Stage Renal Disease (ESRD). Education related to the issue that ESRD patients have access to Medicare Advantage plans. Work on potential legislation to support better integration of care for ESRD patients.

LobbyistCovered position, as disclosed
SARAH HAMLETT —
MEGHAN JOHNSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1130 (114th)

Veterans VET

Issues related to Veterans access to dialysis services.

LobbyistCovered position, as disclosed
SARAH HAMLETT —
MEGHAN JOHNSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.